ResultsIQ

ResultsIQ › Latest results › Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited Q4 FY26 results press release summary

NSE: GAUDIUMIVF · BSE: 544709

Results press release of 28 May 2026, summarised by AI from the filing.

Of 19 new IVF hubs planned under IPO proceeds, 3 expected operational soon, total to reach 10 in FY27, 8 in FY28 and 1 in FY29.

Key takeaways

  1. Hub expansion Of 19 new IVF hubs planned under IPO proceeds, 3 expected operational soon, total to reach 10 in FY27, 8 in FY28 and 1 in FY29.
  2. AI integration In April 2026, became the first IVF chain in India to integrate AI-led embryology with IVF 2.0's SiD and ERICA platforms.
  3. Growth driver FY26 revenue growth driven by higher patient volume at mature hub and high clinical success rate.
  4. Risk No risks or negatives were acknowledged in the document.

Original filing on BSE

Gaudium IVF and Women Health Limited Q1 FY27 results

As filed: Revenue ₹19.4 cr, EBITDA ₹2.4 cr, PAT ₹1.8 cr, EBITDA margin 12.5%.

Not scored. Too small to score: quarter revenue ₹19.4 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹30.4 cr, EBITDA ₹12.2 cr, PAT ₹8.4 cr, EBITDA margin 40.1%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹30.4 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −7.0% in 28 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹24.5 cr, EBITDA ₹6.6 cr, PAT ₹3.6 cr, EBITDA margin 26.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹24.5 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +2.2% in 30 days (Nifty 500: +4.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Gaudium IVF and Women Health Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.